Using changes in binding globulins to assess oral contraceptive pill compliance in clinical trials

2012 ◽  
Vol 98 (3) ◽  
pp. S196
Author(s):  
C.L. Westhoff ◽  
K.A. Petrie ◽  
S. Cremers
2002 ◽  
Vol 10 (4) ◽  
pp. 403-404 ◽  
Author(s):  
Mosunmola Tunde-Ayinmode ◽  
Ashok Singh ◽  
Karen Marsden

Objective: To highlight the therapeutic potential of oestrogen in schizophrenia and raise awareness about the need for more clinical trials. Method: Case Report. Results: The case concerns a woman suffering from chronic paranoid schizophrenia, who complied poorly with antipsychotic medication and had severely impaired psychological and social functioning. Oestrogen therapy in the form of an oral contraceptive pill (brevinor- norethisterone/ ethinyloestradiol) was used with effect. Conclusions: Oestrogen therapy shows promise in select cases in the treatment of schizophrenia and warrants further study.


Sign in / Sign up

Export Citation Format

Share Document